Does high LDL with normal triglycerides suggest impaired LDL clearance?

The described lipid pattern is LDL-predominant rather than the typical triglyceride-rich phenotype associated with insulin resistance. In a 42-year-old woman, persistently marked untreated LDL-C, LDL particle number, non-HDL-C, and total cholesterol merit evaluation for inherited and secondary causes.

Clinical interpretation

• Marked LDL-C and LDL-particle elevation with normal triglycerides is more consistent with impaired LDL clearance or primary hypercholesterolemia—including familial and polygenic forms—than with insulin-resistant combined dyslipidemia.
• Insulin-resistant dyslipidemia is usually driven by increased triglyceride-rich VLDL production and impaired clearance, tending toward high triglycerides, low HDL-C, and small dense LDL particles. LDL-C may remain relatively unremarkable despite increased atherogenic particle burden.
• Favorable triglycerides, insulin, HbA1c, and triglyceride-to-HDL ratio therefore shift the pattern away from insulin-resistant dyslipidemia, but do not rule out insulin resistance. Triglyceride-to-HDL ratio has heterogeneous, population-dependent diagnostic performance; fasting insulin lacks standardized assays and universal cutoffs; and HbA1c reflects glycemia rather than insulin resistance directly.

Mechanistic basis

• Familial hypercholesterolemia causes lifelong LDL elevation through reduced circulating LDL-particle removal.
• LDLR variants can reduce receptor production, function, or cell-surface delivery. APOB variants may impair apoB-100 binding to LDL receptors. Gain-of-function PCSK9 variants accelerate LDL-receptor degradation, collectively reducing hepatic LDL clearance.
• These mechanisms readily explain high LDL-C and LDL particle number despite normal triglycerides.

Clinical implications

• The biochemical profile is not diagnostic on its own. Secondary contributors—such as hypothyroidism, kidney or liver disease, diabetes, diet, alcohol, and medications—should be assessed.
• Persistent LDL-C ≥190 mg/dL particularly supports assessment for inherited hypercholesterolemia, including premature ASCVD family history, physical findings, validated clinical criteria, and consideration of Lp(a) and apoB.

Bottom line

• The claim is moderately supported: this profile is more coherent with impaired LDL clearance or primary hypercholesterolemia than insulin-resistant dyslipidemia, while requiring clinical evaluation to establish the cause.